(Q33441240)

26 July 2017

title

Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats (English)

1 reference

26 July 2017

1 reference

9

Kazuo Kitagawa

1 reference

26 July 2017

Emi Omura-Matsuoka

1

1 reference

26 July 2017

Yoshiki Yagita

2

1 reference

26 July 2017

Tsutomu Sasaki

3

1 reference

26 July 2017

Yasukazu Terasaki

4

1 reference

26 July 2017

Naoki Oyama

5

1 reference

26 July 2017

Yukio Sugiyama

6

1 reference

26 July 2017

Shuhei Okazaki

7

1 reference

26 July 2017

Saburo Sakoda

8

1 reference

26 July 2017

publication date

8 May 2009

1 reference

26 July 2017

published in

Hypertension Research

1 reference

26 July 2017

volume

32

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

548-553

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.69

26 July 2017

exact match

0 references

cites work

Guidelines for the Early Management of Adults With Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Rho-kinase is an important therapeutic target in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Reversible middle cerebral artery occlusion without craniectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

A semiautomated method for measuring brain infarct volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Identification of a putative target for Rho as the serine-threonine kinase protein kinase N

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Cerebral vascular effects of angiotensin II: new insights from genetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

inferred from DOI database lookup

7 January 2021

based on heuristic

Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

inferred from DOI database lookup

7 January 2021

based on heuristic

Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.69

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/HR.2009.69

1 reference

Dimensions Publication ID

26 July 2017

1050672513

0 references

1 reference